Pancreatic cancer (PC) is one of the leading causes of cancer-related death globally. So,
identification of potential molecular signatures is required for diagnosis, prognosis, and …

Background Pancreatic cancer is one of the most common malignant cancers worldwide.
Currently, the pathogenesis of pancreatic cancer remains unclear; thus, it is necessary to …

Background The hunt for the molecular markers with specificity and sensitivity has been a
hot area for the tumor treatment. Due to the poor diagnosis and prognosis of pancreatic …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the world,
and more molecular mechanisms should be illuminated to meet the urgent need of …

Pancreatic cancer (PC) is one of the most common causes of cancer mortality worldwide. As
the genetic mechanism of this complex disease is not uncovered clearly, identification of …

Background Pancreatic cancer (PC) is a malignancy with a poor prognosis and high
mortality. Surgical resection is the only “curative” treatment. However, only a minority of …

Pancreatic cancer is one of the highly invasive and the seventh most common cause of
death among cancers worldwide. To identify essential genes and the involved mechanisms …

Recently, growing evidence has revealed the significant effect of reprogrammed metabolism
on pancreatic cancer in relation to carcinogenesis, progression, and treatment. However, the …

Background Pancreatic carcinoma (PC) is one of the most aggressive cancers affecting
human health. It is essential to identify candidate biomarkers for the diagnosis and …

Background Pancreatic cancer is characterized by its unsatisfying early detection rate, rapid
disease progression and poor prognosis. Further studies on molecular mechanism and …